Puts packaging business on pace for 2 billion by end of year
SCHOTT’s pharmaceutical packaging business unit has delivered enough vials to provide more than 1 billion doses of Covid-19 vaccines, marking a milestone in its contribution to the global fight against the coronavirus, the company says. SCHOTT remains on track to deliver vials for more than 2 billion vaccine doses through 2021.
The vials were delivered to projects across the globe, with a focus on the US, Europe and China. About 90% of approved vaccines rely on SCHOTT vials, according to the company.
SCHOTT is a producer of pharmaceutical containers made from borosilicate glass, which the company says is the most proven and widely available material used to store and deliver vaccines and other sensitive medications. SCHOTT’s global manufacturing footprint includes five sites that are dedicated to the manufacture of type-1 borosilicate glass tubes and another 16 plants converting the tubes into vials.
Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders
March 10th 2025This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.